In ischemia-reperfusion-induced AKI, HDAC inhibitor-treated mice were not protected from initial injury (3 days), but were quicker to recover and protected from subsequent development of fibrosis (28 days) [16]. This evidence concerns the gene HDAC9 and acute kidney injury.